Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$628M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$567M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$392M |
| 5 |
Walmart Inc
WMT
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$451M |
| 2 |
PepsiCo
PEP
|
+$382M |
| 3 |
Philip Morris
PM
|
+$256M |
| 4 |
Roku
ROKU
|
+$252M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.34% |
| 2 | Technology | 12.68% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Financials | 10.32% |
| 5 | Consumer Staples | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
Harvard Bioscience
HBIO
$30.5M
| $1.58M | ﹤0.01% |
51,521
-38,579
| -43% | -$959K |
|
2402
Network-1 Technologies
NTIP
$35.7M
| $1.58M | ﹤0.01% |
678,316
+8,500
| +1% | +$20.8K |
|
|
SPRT
2403
DELISTED
support.com, Inc.
SPRT
| $1.58M | ﹤0.01% |
1,026,536
-3,500
| -0.3% | -$5.52K |
|
2404
Columbia Sportswear
COLM
$2.92B
| $1.58M | ﹤0.01% |
16,302
-103,100
| -86% | -$10.2M |
|
|
GBL
2405
DELISTED
GAMCO Investors, Inc.
GBL
| $1.58M | ﹤0.01% |
80,700
+20,600
| +34% | +$395K |
|
2406
John B. Sanfilippo & Son
JBSS
$1.01B
| $1.57M | ﹤0.01% |
16,300
+10,900
| +202% | +$948K |
|
|
CTIC
2407
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $1.57M | ﹤0.01% |
1,877,889
+281,302
| +18% | +$215K |
|
2408
Kewaunee Scientific
KEQU
$105M
| $1.57M | ﹤0.01% |
100,697
+8,070
| +9% | +$136K |
|
2409
Tredegar Corp
TG
$274M
| $1.57M | ﹤0.01% |
80,400
+44,200
| +122% | +$776K |
|
|
EFC
2410
Ellington Financial
EFC
$1.76B
| $1.57M | ﹤0.01% |
86,800
-142,100
| -62% | -$2.52M |
|
|
FBMS
2411
DELISTED
The First Bancshares, Inc.
FBMS
| $1.57M | ﹤0.01% |
48,500
+24,000
| +98% | +$763K |
|
|
SFBS
2412
ServisFirst Bancshares
SFBS
$5B
| $1.56M | ﹤0.01% |
47,100
+2,300
| +5% | +$74.2K |
|
|
ASNA
2413
DELISTED
Ascena Retail Group, Inc.
ASNA
| $1.55M | ﹤0.01% |
293,770
-292
| -0.1% | -$2.17K |
|
|
PFSW
2414
DELISTED
PFSweb, Inc.
PFSW
| $1.54M | ﹤0.01% |
618,239
+24,400
| +4% | +$74.8K |
|
2415
iShares California Muni Bond ETF
CMF
$4.62B
| $1.54M | ﹤0.01% |
25,100
-32,100
| -56% | -$1.97M |
|
|
JCTC
2416
Jewett-Cameron Trading
JCTC
$10.2M
| $1.54M | ﹤0.01% |
192,475
+1,200
| +0.6% | +$9.73K |
|
|
VNTR
2417
DELISTED
Venator Materials PLC
VNTR
| $1.53M | ﹤0.01% |
628,138
+170,938
| +37% | +$544K |
|
2418
State Street SPDR ICE Preferred Securities ETF
PSK
$683M
| $1.52M | ﹤0.01% |
34,525
-314
| -0.9% | -$13.7K |
|
2419
Perrigo
PRGO
$1.77B
| $1.52M | ﹤0.01% |
27,200
-84,600
| -76% | -$4.31M |
|
2420
Labcorp
LH
$25.9B
| $1.51M | ﹤0.01% |
10,476
-153,532
| -94% | -$22.4M |
|
2421
Merchants Bancorp
MBIN
$2.53B
| $1.51M | ﹤0.01% |
136,913
+34,313
| +33% | +$381K |
|
2422
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
| $1.49M | ﹤0.01% |
46,100
-8,300
| -15% | -$267K |
|
2423
PC Connection
CNXN
$2.06B
| $1.49M | ﹤0.01% |
38,300
+25,902
| +209% | +$921K |
|
2424
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $1.49M | ﹤0.01% |
13,200
-37,000
| -74% | -$4.13M |
|
2425
Genco Shipping & Trading
GNK
$1.15B
| $1.48M | ﹤0.01% |
160,730
-60,270
| -27% | -$573K |
|
Similar funds
Jim Simons's Q3 2019 Portfolio in Review
As of Q3 2019, Jim Simons held 3,920 positions worth $118B, up 4% from $114B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $5.29B of net new capital in Q3 2019, opening 406 new positions and adding to 1,848 existing holdings. Its largest new stake was UnitedHealth: 1,624,826 shares worth $353M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $451M trimmed.
- Jim Simons's largest Q3 2019 buy was UnitedHealth: 1,624,826 shares worth $353M.
- Jim Simons added most to Celgene Corp in Q3 2019, an estimated $628M increase.
- Jim Simons's biggest Q3 2019 reduction was Apple, cutting an estimated $451M.
- Jim Simons fully exited Red Hat Inc in Q3 2019, selling an estimated $248M.
- Jim Simons's ten largest holdings make up 11% of its $118B portfolio in Q3 2019.
- Jim Simons opened 406 new positions and closed 522 in Q3 2019.
- Jim Simons's portfolio value rose 4% quarter-over-quarter to $118B.
Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.